{"title": "Infection Dynamics of Coronavirus Disease 2019 (Covid-19) Modeled with the Integration of the Eyring Rate Process Theory and Free Volume Concept", "doi": "10.1101/2020.02.26.20028571", "citation_id": "2020.02.26.20028571v2", "date": "2020-03-02", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.26.20028571", "abstract": "<p>The Eyrings rate process theory and free volume concept, two very popular theories in chemistry\nand physics fields, are employed to treat infectious disease transmissions. The susceptible individ-\nuals are assumed to move stochastically from one place to another. The virus particle transmission\nrate is assumed to obey the Eyring rate process theory and also controlled by how much free\nvolume available in a system. The transmission process is considered to be a sequential chemical\nreaction, and the concentrations or fractions of four epidemiological compartments, the susceptible,\nthe exposed, the infected, and the removed, can be derived and calculated. The obtained equations\nshow that the basic reproduction number, R0, is not a constant, dependent on the volume frac-\ntion of virus particles, virus particle size, and virus particle packing structure, the energy barrier\nassociated with susceptible individuals, and environment temperature. The developed models are\napplied to treat coronavirus disease 2019 (Covid-19) transmission and make predictions on peak\ntime, peak infected, and R0. Our work provides a simple and straightforward approach to estimate\nhow infection diseases evolve and how many people may be infected.</p>", "twitter_description": "The Eyrings rate process theory and free volume concept, two very popular theories in chemistry and physics fields, are employed to treat infectious disease transmissions. The susceptible individ- uals are assumed to move stochastically from one place to another. The virus particle transmission rate is assumed to obey the Eyring rate process theory and also controlled by how much free volume available in a system. The transmission process is considered to be a sequential chemical reaction, and the concentrations or fractions of four epidemiological compartments, the susceptible, the exposed, the infected, and the removed, can be derived and calculated. The obtained equations show that the basic reproduction number, R0, is not a constant, dependent on the volume frac- tion of virus particles, virus particle size, and virus particle packing structure, the energy barrier associated with susceptible individuals, and environment temperature. The developed models are applied to treat coronavirus disease 2019 (Covid-19) transmission and make predictions on peak time, peak infected, and R0. Our work provides a simple and straightforward approach to estimate how infection diseases evolve and how many people may be infected.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo funding\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nData are provided by CCDC", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20028571v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20028571v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.26.20028571v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/02/2020.02.26.20028571.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.26.20028571v2", "access_rights": "restricted", "authors": ["Tian Hao"]}